In Israel, they found a way to improve the quality of milk without the use of antibiotics

Published 2023년 8월 10일

Tridge summary

Israeli biopharmaceutical company Mileutis has completed clinical trials of a new antimicrobial substitute that improves the quality of milk in dairy cows. The trials were carried out on seven Israeli dairy farms, involving over 500 cows. The results showed an increase in protein and fat content in the milk, as well as an increase in milk yield, which could impact milk prices and benefit the consumer market.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The Israeli biopharmaceutical company Mileutis announced the completion of clinical trials of an antimicrobial substitute developed on its basis. The results showed that the use of the drug improves the quality of milk in dairy cows. It is reported by Reuters. As follows from the Mileutis statement, trials of a new non-steroidal, non-antibiotic drug for the treatment of udder inflammation in cows were carried out on seven Israeli dairy farms in conjunction with Strauss Health, part of which is owned by the French Danone. In total, more than 500 dairy cows were involved in the study. According to the results, in the milk of cows treated, the protein content increased by 7.2%, fat - by 4%. An increase in milk yield was also noted, which increased by 8.6% per cow over 305 days. “In addition to increasing milk yields and ...
Source: Milknews

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.